Page 2 - CUA Mesh Statement 2019

References

1. https://www.fda.gov/medicaldevices/productsandmedicalprocedures/implantsandpros
thetics/urogynsurgicalmesh/
2. http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/39475a-
eng.php
3. Welk, B., Carlson, K. V., Baverstock, R. J., Steele, S. S., Bailly, G. G., & Hickling, D. R.
(2017). Canadian Urological Association position statement on the use of transvaginal
mesh. Canadian Urological Association Journal = Journal De l'Association Des Urologues
Du Canada, 11(6S2), 105–3. http://doi.org/10.5489/cuaj.4579
4. Sammarco, A. G., Swenson, C. W., Kamdar, N. S., Kobernik, E. K., DeLancey, J. O. L.,
Nallamothu, B., & Morgan, D. M. (2018). Rate of Pelvic Organ Prolapse Surgery Among
Privately Insured Women in the United States, 2010-2013. Obstetrics and Gynecology,
131(3), 484–492. http://doi.org/10.1097/AOG.0000000000002485
5. Jha, S., Cutner, A., & Moran, P. (2018). The UK National Prolapse Survey: 10 years on.
International Urogynecology Journal, 29(6), 795–801. http://doi.org/10.1007/s00192-
017-3476-3
6. https://www.medscape.com/viewarticle/911882